Poster: AML-122 Midostaurin Maintenance versus Allo SCT versus W&W in FLT3-Mutated AML: A “Real-Life” Multicenter Study

Adolfo de la Fuente,Marina Diaz Beya,Paola Beneit, Ainhoa Fernandez Moreno,Montserrat Arnan Sangerman,Ana Garrido, Susana Vives Polo, Maria Garcia Fortes,Antonia Sampol Mayol,Jorge Labrador,Antoni Garcia Guinon, Cristina Gil Cortes,Juan Bergua,Mayte Olave,Maria Luz Amigo,Xavi Ortin, Ferran V Poster,Monica Estevez,Antonio Diaz-Lopez,Josefina Serrano

Clinical Lymphoma Myeloma and Leukemia（2022）

引用 0|浏览8

暂无评分

摘要

Our experience confirms the safety of maintenance therapy in AML FLT3 patients after IC. We also observed a benefit for maintenance versus W&W in the low- and intermediate-risk population.

查看译文

关键词

AML,leukemia,FLT3,midostaurin,maintenance

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要